Evaluation of the effect of symptomatic upper respiratory infections on pharmacological characteristics of Technosphere/insulin in subjects with diabetes mellitus after a meal challenge
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2015
At a glance
- Drugs Insulin (Primary) ; Antihypoglycaemics
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 07 Jun 2017 Biomarkers information updated
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 22 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.